Joinville Le Pont, France

Laurence De Cruz

This inventor holds 1 USPTO granted patent. Top assignee: Synthelabo. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurence De Cruz. Retrieved from https://idiyas.com/inventor/laurence-de-cruz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Laurence De Cruz

Introduction

Laurence De Cruz is a notable inventor based in Joinville Le Pont, France. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. His work has led to the creation of innovative derivatives that have potential applications in various therapeutic areas.

Latest Patents

One of Laurence De Cruz's key patents is for 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives. This invention showcases his expertise in synthesizing complex chemical structures that may have important implications in drug development. He holds 1 patent in this area, reflecting his commitment to advancing scientific knowledge.

Career Highlights

Laurence De Cruz is currently employed at Synthelabo, a company known for its focus on pharmaceutical research and development. His role at Synthelabo allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to innovative solutions in healthcare.

Collaborations

Throughout his career, Laurence has worked alongside esteemed colleagues such as Frederic Galli and Axelle Solignac. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

In summary, Laurence De Cruz is a dedicated inventor whose work in the field of chemistry has led to significant advancements in pharmaceutical compounds. His innovative spirit and collaborative efforts continue to drive progress in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…